Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 2-3/2010

01.04.2010

Challenges for the Autoimmunologist

verfasst von: Torsten Matthias, Yehuda Shoenfeld

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 2-3/2010

Einloggen, um Zugang zu erhalten

Abstract

Every 2 years, an International Congress of Autoimmunity is organized and held with the intent of creating a new base for continuing interdisciplinary and international research, including further opportunities to train in the field of autoimmunity. In September 2008, the Congress of Autoimmunity was held in Porto, Portugal, and over the next 6 months, requests were made from a number of key investigators to provide copies of their papers for publication in a special volume of this journal. In addition, a satellite meeting sponsored by the AESKU.KIPP Institute was held in Porto with an attempt of focusing on specific challenges faced by the autoimmunologist. It is hoped that this collection of papers will become a valuable source for researchers in autoimmunity.
Literatur
1.
Zurück zum Zitat Abraham NG, Li M, Vanella L, Peterson SJ, Ikehara S, Asprinio D (2008) Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmun 30:128–135CrossRefPubMed Abraham NG, Li M, Vanella L, Peterson SJ, Ikehara S, Asprinio D (2008) Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmun 30:128–135CrossRefPubMed
2.
Zurück zum Zitat Akeno N, Blackard JT, Tomer Y (2008) HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun 31:339–344CrossRefPubMed Akeno N, Blackard JT, Tomer Y (2008) HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun 31:339–344CrossRefPubMed
3.
Zurück zum Zitat Askenasy N, Kaminitz A, Yarkoni S (2008) Mechanisms of T regulatory cell function. Autoimmun Rev 7:370–375CrossRefPubMed Askenasy N, Kaminitz A, Yarkoni S (2008) Mechanisms of T regulatory cell function. Autoimmun Rev 7:370–375CrossRefPubMed
4.
Zurück zum Zitat Baker RL, Wagner DH Jr, Haskins K (2008) CD40 on NOD CD4 T cells contributes to their activation and pathogenicity. J Autoimmun 31:385–392CrossRefPubMed Baker RL, Wagner DH Jr, Haskins K (2008) CD40 on NOD CD4 T cells contributes to their activation and pathogenicity. J Autoimmun 31:385–392CrossRefPubMed
5.
Zurück zum Zitat Bartunkova J, Kayserova J, Shoenfeld Y (2009) Allergy and autoimmunity: parallels and dissimilarity: the yin and yang of immunopathology. Autoimmun Rev 8:302–308CrossRefPubMed Bartunkova J, Kayserova J, Shoenfeld Y (2009) Allergy and autoimmunity: parallels and dissimilarity: the yin and yang of immunopathology. Autoimmun Rev 8:302–308CrossRefPubMed
6.
Zurück zum Zitat Bazzani C, Filippini M, Caporali R, Bobbio-Pallavicini F, Favalli EG, Marchesoni A, Atzeni F, Sarzi-Puttini P, Gorla R (2009) Anti-TNF alpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes. Autoimmun Rev 8:260–265CrossRefPubMed Bazzani C, Filippini M, Caporali R, Bobbio-Pallavicini F, Favalli EG, Marchesoni A, Atzeni F, Sarzi-Puttini P, Gorla R (2009) Anti-TNF alpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes. Autoimmun Rev 8:260–265CrossRefPubMed
7.
Zurück zum Zitat Boren EJ, Cheema GS, Naguwa SM, Ansari AA, Gershwin ME (2008) The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 30:90–98CrossRefPubMed Boren EJ, Cheema GS, Naguwa SM, Ansari AA, Gershwin ME (2008) The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 30:90–98CrossRefPubMed
8.
Zurück zum Zitat Burt RK, Testori A, Craig R, Cohen B, Suffit R, Barr W (2008) Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned? J Autoimmun 30:116–120CrossRefPubMed Burt RK, Testori A, Craig R, Cohen B, Suffit R, Barr W (2008) Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned? J Autoimmun 30:116–120CrossRefPubMed
9.
Zurück zum Zitat Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR (2008) Pituitary autoimmunity: 30 years later. Autoimmun Rev 7:631–637CrossRefPubMed Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR (2008) Pituitary autoimmunity: 30 years later. Autoimmun Rev 7:631–637CrossRefPubMed
10.
Zurück zum Zitat Dalloul A (2009) CD5: a safeguard against autoimmunity and a shield for cancer cells. Autoimmun Rev 8:349–353CrossRefPubMed Dalloul A (2009) CD5: a safeguard against autoimmunity and a shield for cancer cells. Autoimmun Rev 8:349–353CrossRefPubMed
11.
12.
Zurück zum Zitat Greene MT, Ercolini AM, DeGutes M, Miller SD (2008) Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor. J Autoimmun 31:399–407CrossRefPubMed Greene MT, Ercolini AM, DeGutes M, Miller SD (2008) Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor. J Autoimmun 31:399–407CrossRefPubMed
13.
Zurück zum Zitat Hogan TV, Ang DK, Gleeson PA, van Driel IR (2008) Extrathymic mechanisms of T cell tolerance: lessons from autoimmune gastritis. J Autoimmun 31:268–273CrossRefPubMed Hogan TV, Ang DK, Gleeson PA, van Driel IR (2008) Extrathymic mechanisms of T cell tolerance: lessons from autoimmune gastritis. J Autoimmun 31:268–273CrossRefPubMed
14.
Zurück zum Zitat Hu N, Westra J, Kallenberg CG (2009) Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's granulomatosis. Autoimmun Rev 8:510–514CrossRefPubMed Hu N, Westra J, Kallenberg CG (2009) Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's granulomatosis. Autoimmun Rev 8:510–514CrossRefPubMed
15.
Zurück zum Zitat Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M (2008) Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmun 31:175–179CrossRefPubMed Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M (2008) Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmun 31:175–179CrossRefPubMed
16.
Zurück zum Zitat Jennings P, Chan A, Schwartzberg P, Wakeland EK, Yuan D (2008) Antigen-specific responses and ANA production in B6.Sle1b mice: a role for SAP. J Autoimmun 31:345–353CrossRefPubMed Jennings P, Chan A, Schwartzberg P, Wakeland EK, Yuan D (2008) Antigen-specific responses and ANA production in B6.Sle1b mice: a role for SAP. J Autoimmun 31:345–353CrossRefPubMed
17.
Zurück zum Zitat Jordan MA, Baxter AG (2008) The genetics of immunoregulatory T cells. J Autoimmun 31:237–244CrossRefPubMed Jordan MA, Baxter AG (2008) The genetics of immunoregulatory T cells. J Autoimmun 31:237–244CrossRefPubMed
18.
Zurück zum Zitat Katzav A, Ben-Ziv T, Chapman J, Blank M, Reichlin M, Shoenfeld Y (2008) Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J Autoimmun 31:393–398CrossRefPubMed Katzav A, Ben-Ziv T, Chapman J, Blank M, Reichlin M, Shoenfeld Y (2008) Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J Autoimmun 31:393–398CrossRefPubMed
19.
Zurück zum Zitat Kerr EC, Raveney BJ, Copland DA, Dick AD, Nicholson LB (2008) Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J Autoimmun 31:354–361CrossRefPubMed Kerr EC, Raveney BJ, Copland DA, Dick AD, Nicholson LB (2008) Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J Autoimmun 31:354–361CrossRefPubMed
20.
Zurück zum Zitat Klein RS, Sayre RM, Dowdy JC, Werth VP (2009) The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus. Autoimmun Rev 8:320–324CrossRefPubMed Klein RS, Sayre RM, Dowdy JC, Werth VP (2009) The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus. Autoimmun Rev 8:320–324CrossRefPubMed
21.
Zurück zum Zitat La Cava A (2008) Tregs are regulated by cytokines: implications for autoimmunity. Autoimmun Rev 8:83–87CrossRefPubMed La Cava A (2008) Tregs are regulated by cytokines: implications for autoimmunity. Autoimmun Rev 8:83–87CrossRefPubMed
22.
Zurück zum Zitat Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M (2008) Is autoimmunity a matter of sex? Autoimmun Rev 7:626–630CrossRefPubMed Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M (2008) Is autoimmunity a matter of sex? Autoimmun Rev 7:626–630CrossRefPubMed
23.
Zurück zum Zitat Lleo A, Selmi C, Invernizzi P, Podda M, Gershwin ME (2008) The consequences of apoptosis in autoimmunity. J Autoimmun 31:257–262CrossRefPubMed Lleo A, Selmi C, Invernizzi P, Podda M, Gershwin ME (2008) The consequences of apoptosis in autoimmunity. J Autoimmun 31:257–262CrossRefPubMed
24.
Zurück zum Zitat Marmont AM (2008) Will hematopoietic stem cell transplantation cure human autoimmune diseases? J Autoimmun 30:145–150CrossRefPubMed Marmont AM (2008) Will hematopoietic stem cell transplantation cure human autoimmune diseases? J Autoimmun 30:145–150CrossRefPubMed
25.
Zurück zum Zitat Marttila J, Huttunen S, Vaarala O, Suzuki K, Elliott JF, Narvanen A, Knip M, Simell O, Ilonen J (2008) T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies. J Autoimmun 31:142–148CrossRefPubMed Marttila J, Huttunen S, Vaarala O, Suzuki K, Elliott JF, Narvanen A, Knip M, Simell O, Ilonen J (2008) T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies. J Autoimmun 31:142–148CrossRefPubMed
26.
Zurück zum Zitat Mathieu A, Paladini F, Vacca A, Cauli A, Fiorillo MT, Sorrentino R (2009) The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun Rev 8:420–425CrossRefPubMed Mathieu A, Paladini F, Vacca A, Cauli A, Fiorillo MT, Sorrentino R (2009) The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun Rev 8:420–425CrossRefPubMed
27.
Zurück zum Zitat Miller A, Basu N, Luqmani R (2008) Assessment of systemic vasculitis. Autoimmun Rev 8:170–175CrossRefPubMed Miller A, Basu N, Luqmani R (2008) Assessment of systemic vasculitis. Autoimmun Rev 8:170–175CrossRefPubMed
28.
Zurück zum Zitat Neuhausen SL, Steele L, Ryan S, Mousavi M, Pinto M, Osann KE, Flodman P, Zone JJ (2008) Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 31:160–165CrossRefPubMed Neuhausen SL, Steele L, Ryan S, Mousavi M, Pinto M, Osann KE, Flodman P, Zone JJ (2008) Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 31:160–165CrossRefPubMed
29.
Zurück zum Zitat Pai S, Thomas R (2008) Immune deficiency or hyperactivity-NF-kappa b illuminates autoimmunity. J Autoimmun 31:245–251CrossRefPubMed Pai S, Thomas R (2008) Immune deficiency or hyperactivity-NF-kappa b illuminates autoimmunity. J Autoimmun 31:245–251CrossRefPubMed
30.
Zurück zum Zitat Perricone R, Perricone C, De Carolis C, Shoenfeld Y (2008) NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun Rev 7:384–390CrossRefPubMed Perricone R, Perricone C, De Carolis C, Shoenfeld Y (2008) NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun Rev 7:384–390CrossRefPubMed
31.
Zurück zum Zitat Rezvani AR, Storb RF (2008) Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 30:172–179CrossRefPubMed Rezvani AR, Storb RF (2008) Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 30:172–179CrossRefPubMed
32.
Zurück zum Zitat Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US, Herrmann M (2008) Clearance deficiency—a potential link between infections and autoimmunity. Autoimmun Rev 8:5–8CrossRefPubMed Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US, Herrmann M (2008) Clearance deficiency—a potential link between infections and autoimmunity. Autoimmun Rev 8:5–8CrossRefPubMed
33.
Zurück zum Zitat Shimoda S, Miyakawa H, Nakamura M, Ishibashi H, Kikuchi K, Kita H, Niiro H, Arinobu Y, Ono N, Mackay IR, Gershwin ME, Akashi K (2008) CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 31:110–115CrossRefPubMed Shimoda S, Miyakawa H, Nakamura M, Ishibashi H, Kikuchi K, Kita H, Niiro H, Arinobu Y, Ono N, Mackay IR, Gershwin ME, Akashi K (2008) CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 31:110–115CrossRefPubMed
34.
Zurück zum Zitat Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31:325–330CrossRefPubMed Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31:325–330CrossRefPubMed
35.
Zurück zum Zitat Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S, Carerj S, Turiel M (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8:281–286CrossRefPubMed Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, Antonini-Canterin F, Di Salvo G, De Gennaro Colonna V, La Carrubba S, Carerj S, Turiel M (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8:281–286CrossRefPubMed
36.
Zurück zum Zitat Skorstad G, Hestvik AL, Vartdal F, Holmoy T (2009) Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J Autoimmun 32:24–32CrossRefPubMed Skorstad G, Hestvik AL, Vartdal F, Holmoy T (2009) Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J Autoimmun 32:24–32CrossRefPubMed
37.
Zurück zum Zitat Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmas P, Szamosi S, Szanto J, Kiss E (2008) Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. J Autoimmun 31:372–376CrossRefPubMed Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmas P, Szamosi S, Szanto J, Kiss E (2008) Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. J Autoimmun 31:372–376CrossRefPubMed
38.
Zurück zum Zitat Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T (2008) Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev 8:134–138CrossRefPubMed Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T (2008) Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev 8:134–138CrossRefPubMed
39.
Zurück zum Zitat Vital EM, Emery P (2008) The development of targeted therapies in rheumatoid arthritis. J Autoimmun 31:219–227CrossRefPubMed Vital EM, Emery P (2008) The development of targeted therapies in rheumatoid arthritis. J Autoimmun 31:219–227CrossRefPubMed
40.
Zurück zum Zitat Yeh S, Wroblewski K, Buggage R, Li Z, Kurup SK, Sen HN, Dahr S, Sran P, Reed GF, Robinson R, Ragheb JA, Waldmann TA, Nussenblatt RB (2008) High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. J Autoimmun 31:91–97CrossRefPubMed Yeh S, Wroblewski K, Buggage R, Li Z, Kurup SK, Sen HN, Dahr S, Sran P, Reed GF, Robinson R, Ragheb JA, Waldmann TA, Nussenblatt RB (2008) High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. J Autoimmun 31:91–97CrossRefPubMed
Metadaten
Titel
Challenges for the Autoimmunologist
verfasst von
Torsten Matthias
Yehuda Shoenfeld
Publikationsdatum
01.04.2010
Verlag
Humana Press Inc
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 2-3/2010
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-009-8141-2

Weitere Artikel der Ausgabe 2-3/2010

Clinical Reviews in Allergy & Immunology 2-3/2010 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.